Inari Medical Equity 2024

Inari Medical Aktienanalyse

What does Inari Medical do?

Inari Medical Inc. is an American medical technology company founded in 2013 and headquartered in Irvine, California. The company specializes in the development and manufacturing of medical devices for the treatment of vascular diseases. The founders of Inari Medical are Vinayak "Vin" P. Kasabwala and Dr. Thomas "Thom" C. Fogarty. Dr. Fogarty is a well-known pioneer in the field of minimally invasive surgery and has filed more than 160 patents. Both founders have an impressive track record in the development and marketing of medical technology products. Inari Medical's business model is based on the development and marketing of products for the minimally invasive treatment of vascular diseases. The company's goal is to develop medical devices that improve the treatment of these diseases and allow patients to recover faster. Inari Medical is divided into various business units, each specializing in the treatment of different types of vascular diseases. The "VENA" business unit focuses on the treatment of vein diseases such as deep vein thrombosis or blockages of larger veins. The "TROMBUS" business unit is dedicated to the treatment of blood clots in the veins that can be life-threatening. Inari Medical's portfolio includes various medical devices that can be used for this purpose. These include catheters that use ultrasound waves to destroy blood clots without damaging the surrounding tissue. The "PULMUS" business unit specializes in the treatment of pulmonary embolisms, which are blockages of the lung arteries caused by a blood clot. Pulmonary embolisms can be life-threatening and require immediate treatment. Inari Medical Inc. has various products on the market that can be used for the treatment of vascular diseases. These include the ClotTriever thrombectomy catheter, the ClotTriever system, and the FlowTriever system. These products enable fast and effective treatment of vein diseases, blood clots, and pulmonary embolisms. The ClotTriever system is a specially designed catheter that removes compact blood clots that form in the veins and large blood vessels. A special filter system is used to prevent the blood clot from entering other parts of the body. The FlowTriever system, on the other hand, is used for the treatment of pulmonary embolisms. A special catheter is inserted into the pulmonary artery to remove the blood clot and restore blood flow to the lungs. The FlowTriever system is designed to quickly and effectively remove the blood clot without damaging the surrounding tissue. Inari Medical aims to revolutionize the treatment of vascular diseases and enable patients to recover faster. The company has an impressive track record in the development and marketing of medical devices and will continue to offer innovative solutions for the treatment of vascular diseases in the future. Inari Medical ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Inari Medical's Equity

Inari Medical's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Inari Medical's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Inari Medical's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Inari Medical's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Inari Medical’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Inari Medical stock

What is the equity of Inari Medical this year?

Inari Medical has equity of 464.91 M USD this year.

What was the equity of Inari Medical compared to the previous year?

The equity of Inari Medical has increased/decreased by 11.49% increased compared to the previous year.

What impact does a high equity have on investors of Inari Medical?

A high equity is advantageous for investors of Inari Medical as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Inari Medical?

A low equity can be a risk for investors of Inari Medical, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Inari Medical affect the company?

An increase in equity of Inari Medical can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Inari Medical affect the company?

A reduction in equity of Inari Medical can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Inari Medical?

Some factors that can affect the equity of Inari Medical include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Inari Medical so important for investors?

The equity of Inari Medical is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Inari Medical take to change the equity?

To change equity, Inari Medical can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Inari Medical pay?

Over the past 12 months, Inari Medical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Inari Medical is expected to pay a dividend of 0 USD.

What is the dividend yield of Inari Medical?

The current dividend yield of Inari Medical is .

When does Inari Medical pay dividends?

Inari Medical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Inari Medical?

Inari Medical paid dividends every year for the past 0 years.

What is the dividend of Inari Medical?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Inari Medical located?

Inari Medical is assigned to the 'Health' sector.

Wann musste ich die Aktien von Inari Medical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Inari Medical from 7/7/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/7/2024.

When did Inari Medical pay the last dividend?

The last dividend was paid out on 7/7/2024.

What was the dividend of Inari Medical in the year 2023?

In the year 2023, Inari Medical distributed 0 USD as dividends.

In which currency does Inari Medical pay out the dividend?

The dividends of Inari Medical are distributed in USD.